We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Nivolumab for Treatment of Squamous Cell Carcinoma of the Skin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04204837
Recruitment Status : Active, not recruiting
First Posted : December 19, 2019
Last Update Posted : March 17, 2021
Bristol-Myers Squibb
Information provided by (Responsible Party):
Martin Laimer, MD, MSc, Salzburger Landeskliniken

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 31, 2021
Estimated Study Completion Date : December 2023